High dose-intensity chemotherapy, with accelerated cyclophosphamide-doxorubicin-etoposide and granulocyte-macrophage colony stimulating factor, in the treatment of small cell lung cancer

This publication has 21 references indexed in Scilit:

• Effects of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Myelosuppression induced by Multiple Cycles of High-Dose Chemotherapy in Patients With Advanced Breast Cancer
  JNCI Journal of the National Cancer Institute, 1991
• Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer
  New England Journal of Medicine, 1991
• Accelerated chemotherapy with or without GM-CSF for small cell lung cancer: a non-randomised pilot study
  European Journal of Cancer and Clinical Oncology, 1990
• Intensive chemotherapy of small cell lung cancer
  Lung Cancer, 1989
• Chemotherapy of small-cell lung cancer: duration of treatment
  Lung Cancer, 1989
• Clinical Use of Recombinant Human Hematopoietic Growth Factors
  JNCI Journal of the National Cancer Institute, 1989
• The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer
  British Journal of Cancer, 1989
• Optimal two-stage designs for phase II clinical trials
  Controlled Clinical Trials, 1989
• Kinetics of human hemopoietic cells after in vivo administration of granulocyte-macrophage colony-stimulating factor.
  Journal of Clinical Investigation, 1989
• Review: Small-Cell Lung Cancer: Current Perspectives
  The Lancet Healthy Longevity, 1987